Capital Link Greece | Investing In Greece

Results: « Previous 1 2 ... 7831 7832 7833 7834 7835 7836 7837 ... 13677 13678 Next »

Market news

London unlikely to regain lost EU share trading, warn City figures

06/01/2021 18:01 - UK has given up about €6bn of daily volume since Brexit transition ended ...

Commodities trader Trafigura sets first emissions reduction target

06/01/2021 17:01 - Move shows how even largely privately owned industry faces pressure to cut carbon footprint ...

Commodities trader Trafigura sets first emissions reduction target

06/01/2021 17:01 - Move shows how even largely privately owned industry faces pressure to cut carbon footprint ...

Protagonist Therapeutics initiated at overweight with $35 price target at JPMorgan

06/01/2021 17:01 - This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. ...

U.S. factory orders up 1% in November

Scholar Rock Holding initiated at overweight at JPMorgan with $59 price target

06/01/2021 16:01 - This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. ...

Vericel price target raised to $40 from $30 at Truist Securities, stock rated buy

Nevro price target raised to $205 from $175 at Truist Securities, stock rated buy

iRhythm Technologies price target raised to $265 from $240 at Truist Securities, stock rated buy

New York Stock Exchange reverses course again on China delistings

06/01/2021 16:01 - Exchange operator will drop three telecoms after criticism from US Treasury for initial backtrack ...

Results: « Previous 1 2 ... 7831 7832 7833 7834 7835 7836 7837 ... 13677 13678 Next »

News

Market news

London unlikely to regain lost EU share trading, warn City figures

Commodities trader Trafigura sets first emissions reduction target

Commodities trader Trafigura sets first emissions reduction target

Protagonist Therapeutics initiated at overweight with $35 price target at JPMorgan

U.S. factory orders up 1% in November

Scholar Rock Holding initiated at overweight at JPMorgan with $59 price target

Vericel price target raised to $40 from $30 at Truist Securities, stock rated buy

Nevro price target raised to $205 from $175 at Truist Securities, stock rated buy

iRhythm Technologies price target raised to $265 from $240 at Truist Securities, stock rated buy

New York Stock Exchange reverses course again on China delistings